L68I (p.Leu68Ile) variant of CYBB (NADPH oxidase 2)
L68I (p.Leu68Ile) in CYBB (NADPH oxidase 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
L68I (p.Leu68Ile) variant details
- p.Leu68Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available